Preclinical Activity of 4-Demethyl-4-cholesteryloxycarbonylpenclomedine in Melanoma. Friedlander P, Morgan LR, Benes EN, Rodgers AH, et al. Anticancer Res 2023;43:1407-1413.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Friedlander P, Morgan LR, Benes EN, Rodgers AH, et al. Preclinical Activity of 4-Demethyl-4-cholesteryloxycarbonylpenclomedine in Melanoma. Anticancer Res 2023;43:1407-1413.
PMID: 36974829